People · Operator
Named in public records as an officer, director or promoter · active 2008–2019 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Athenex, Inc. | — | Pharmaceuticals | Series C | $366.7M | $2.1B | 2009 |
| Pharminex, L.L.C. | — | Pharmaceuticals | Series A | $12.3M | $97.5M | 2008 |
| W.E. Equity Associates, LLC | — | Other | Pre-Seed | $1.0M | $23.1M | 2019 |
Charles Lannon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Lannon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Murphy | 1 | 21 |
| Johnson Lau | 1 | 3 |
| Jean-Pierre Sommadossi | 1 | 3 |
| Simon Pedder | 1 | 3 |
| Jeffrey Yordon | 1 | 3 |
| Allen Barnett | 1 | 2 |
| James Hussey | 1 | 2 |
| Charles E Lannon | 1 | 2 |
| Li Shen | 1 | 2 |
| Rudolf Kwan | 1 | 1 |
| John Vierling | 1 | 1 |
| Benson Tsang | 1 | 1 |
| John Koh | 1 | 1 |
| Jordan Kanfer | 1 | 1 |
| Manson Fok | 1 | 1 |
| Stephanie Davis | 1 | 1 |
| William Zuo | 1 | 1 |
| Kim Campbell | 1 | 1 |
| SongYi Zhang | 1 | 1 |
| Simon Kwan Hung Pedder | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.